Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:36:37.036Z.
Calculation as of: 2026-10-06T19:36:37.036Z.
Quote observation: 2026-10-06T19:35:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f130e36c5816a2cced4d00ccb7d778b7baaa6bfdcaf5b95b3974dc9f748ee68d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
FibroBiologics, Inc. Common Stock
Market Cap
$2.37M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.37M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.37M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.35M | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.36M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.30M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.46M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.11M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
